Home NDC 0019-0862 Cysto-Conray II
Product NDC 0019-0862
11-digit product format 000190862
Labeler code 0019
Product ID 0019-0862_ff628e06-2cb5-4714-a741-1dec04bd5602
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Iothalamate meglumine
Dosage form INJECTION
Route URETERAL
Labeler Liebel-Flarsheim Company LLC
Application NDA017057
Marketing category NDA
Marketing start 2010-10-08
Substance IOTHALAMATE MEGLUMINE
Active strength 172 mg/mL
Pharmacologic classes Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N017057-002 CYSTO-CONRAY II IOTHALAMATE MEGLUMINE 17.2% SOLUTION / INTRAVESICAL Approved before 1982
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N017057-002 CYSTO-CONRAY II 17.2% SOLUTION / INTRAVESICAL Approved before 1982 cb3db0bc1861…
Additional Listing Data#
Finished product Yes
Brand name base Cysto-Conray II
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength IOTHALAMATE MEGLUMINE 172 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination XUW72GOP7W Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0019-0862-50 Cysto-Conray II 250 mL in 1 BOTTLE, GLASS INJECTION 250 18 0019-0862-50 Cysto-Conray II 12 in 1 BOX INJECTION 12 18
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0019-0862 CYSTO-CONRAY II (IOTHALAMATE MEGLUMINE) INJECTION [LIEBEL-FLARSHEIM COMPANY LLC] 18 Current NDC, Legacy NDC, 2 package rows 20210110_8841ab4d-674d-4beb-88a5-13e35f6005cc.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0019-0862-50 00019086250 12 BOTTLE, GLASS in 1 BOX (0019-0862-50) / 250 mL in 1 BOTTLE, GLASS 2010-10-08 0000-00-00 No No Current